preparation and characterization of nanosuspensions of triiodoaniline derivative new contrast agent, and investigation into its cytotoxicity and contrast properties

Iodine-based contrast agents have limitations such as rapid clearance, potential renal toxicity, non-specific blood pool distribution, headache, and adverse events. nowadays, it is quite common to work with nanosized systems in order to eliminate the side effects of contrast agents. this study aims to synthesize a new iodinated contrast agent, prepare its nanosuspension by using the nanoprecipitation method, investigate its cytotoxicity, and compare its contrast properties with iohexol and iopromide through in-vitro experiments. the values of nanosuspension particle size and zeta potential have been found to be ~400 nm and ~(-)15 mv, respectively. in-vitro cellular viability findings indicated that the nanosuspension has lower cytotoxicity than the iohexol and iopromide. in the computed tomography (ct) imaging study of contrast features of nanosuspensions and two commercial agents, which involved 86 ct examinations using 31 parameters and two different devices, it was found that iodine had a stronger presence in its nanosuspension form than in iohexol and iopromide, which were the other two commercial contrast agents, when used in equal amounts. thus in the case of nanosuspensions contrast brightness was achieved by using less iodine, while the same brightness could be obtained with higher doses of iohexol and iopromide. ct imaging therefore be done without much chemical use, which indicates that it may witness fewer side effects in the future.